Ciguatera fish poisoning is a distinctive form of ichthyosarcotoxism charac
terised mainly by gastrointestinal and neurological disturbances. The cigua
toxins, responsible for this poisoning, are complex polyethers produced by
toxic strains of the dinoflagellate Gambierdiscus toxicus. These toxins are
increased to dangerous levels for man during their transmission through he
rbivorous and carnivorous fish, various species being contaminated. The kno
wn molecular target of ciguatoxins is the voltage-gated Na+ channel. During
the action of these toxins, the permanent opening of channels, at the rest
ing membrane potential, produces a continuous entry of Naf ions in excitabl
e cells causing a marked increase in membrane excitability and in cellular
volume. To precise the neurocellular basis of the efficacy of some agents u
sed in clinical and traditional treatments of ciguatera, their effects were
studied on frog myelinated axons exposed to Pacific ciguatoxin-1B (CTX-1B)
. During the action of this toxin, the increase in axonal volume and membra
ne excitability was reversed by lidocaine (a local anaesthetic), by CaCl2 a
nd by hyperosmotic external solutions (containing D-mannitol, sucrose or te
tramethylammonium chloride). The CTX-1B-induced hyperexcitability of the me
mbrane was also reversed by extracts of Argusia argentea leaves or Davallia
solida rhizomes, used traditionally in New-Caledonia. It is concluded that
the various agents studied are able to counteract the neurocellular effect
s of CTX-1B in myelinated axons. These results are of particular interest s
ince they provide a scientific basis to understand the beneficial action of
therapeutic agents used in the treatment of ciguatera fish poisoning.